Atlas Trials

Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL

Clinical trial NCT05215405 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT05215405
Sponsor
Kathleen Ludwig
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Relapsed Childhood ALLRelapsed Childhood Lymphoblastic Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.